Artelo Biosciences Stock Performance
| ARTL Stock | USD 1.28 0.04 3.03% |
The firm shows a Beta (market volatility) of 1.09, which signifies a somewhat significant risk relative to the market. Artelo Biosciences returns are very sensitive to returns on the market. As the market goes up or down, Artelo Biosciences is expected to follow. Artelo Biosciences has an expected return of -0.0778%. Please make sure to confirm Artelo Biosciences treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Artelo Biosciences performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Artelo Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Artelo Biosciences is not utilizing all of its potentials. The newest stock price mess, may contribute to short-term losses for the institutional investors. ...more
Last Split Factor 1:15 | Dividend Date 2019-06-21 | Last Split Date 2022-08-10 |
1 | Artelo Biosciences Shares Down 2 | 02/15/2024 |
2 | Disposition of 1083 shares by Matsui Connie of Artelo Biosciences at 2.01 subject to Rule 16b-3 | 02/28/2024 |
3 | Acquisition by Kelly Steven of 667 shares of Artelo Biosciences at 1.55 subject to Rule 16b-3 | 03/01/2024 |
4 | Artelo Biosciences Selected as a Finalist in Johnson Johnsons Innovation Challenge | 03/12/2024 |
5 | Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update | 03/25/2024 |
6 | Artelo Biosciences Buy Rating Reaffirmed at HC Wainwright - Defense World | 04/03/2024 |
7 | Disposition of 667 shares by Matsui Connie of Artelo Biosciences at 15.0 subject to Rule 16b-3 | 04/05/2024 |
| Begin Period Cash Flow | 12.2 M | |
| Free Cash Flow | -8 M |
Artelo |
Artelo Biosciences Relative Risk vs. Return Landscape
If you would invest 139.00 in Artelo Biosciences on January 20, 2024 and sell it today you would lose (11.00) from holding Artelo Biosciences or give up 7.91% of portfolio value over 90 days. Artelo Biosciences is currently does not generate positive expected returns and assumes 3.2787% risk (volatility on return distribution) over the 90 days horizon. In different words, 28% of stocks are less volatile than Artelo, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Artelo Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Artelo Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Artelo Biosciences, and traders can use it to determine the average amount a Artelo Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0237
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ARTL |
Estimated Market Risk
| 3.28 actual daily | 29 71% of assets are more volatile |
Expected Return
| -0.08 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Artelo Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Artelo Biosciences by adding Artelo Biosciences to a well-diversified portfolio.
Artelo Biosciences Fundamentals Growth
Artelo Stock prices reflect investors' perceptions of the future prospects and financial health of Artelo Biosciences, and Artelo Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Artelo Stock performance.
| Return On Equity | -0.6 | ||||
| Return On Asset | -0.37 | ||||
| Current Valuation | (6.27 M) | ||||
| Shares Outstanding | 3.23 M | ||||
| Price To Earning | 16.31 X | ||||
| Price To Book | 0.42 X | ||||
| EBITDA | (10.29 M) | ||||
| Net Income | (10.08 M) | ||||
| Cash And Equivalents | 21.32 M | ||||
| Cash Per Share | 7.51 X | ||||
| Total Debt | 63 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 42.28 X | ||||
| Book Value Per Share | 3.69 X | ||||
| Cash Flow From Operations | (8.01 M) | ||||
| Earnings Per Share | (3.14) X | ||||
| Market Capitalization | 4.13 M | ||||
| Total Asset | 20.42 M | ||||
| Retained Earnings | (31.02 M) | ||||
| Working Capital | 9.69 M | ||||
| Current Asset | 99.89 M | ||||
| Current Liabilities | 23.67 M | ||||
About Artelo Biosciences Performance
To evaluate Artelo Biosciences Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Artelo Biosciences generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Artelo Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Artelo Biosciences market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Artelo's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 0.00 | 0.00 | |
| Return On Tangible Assets | (0.48) | (0.51) | |
| Return On Capital Employed | (0.61) | (0.58) | |
| Return On Assets | (0.44) | (0.46) | |
| Return On Equity | (0.59) | (0.56) |
Things to note about Artelo Biosciences performance evaluation
Checking the ongoing alerts about Artelo Biosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Artelo Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Artelo Biosciences generated a negative expected return over the last 90 days | |
| Artelo Biosciences may become a speculative penny stock | |
| Artelo Biosciences has high historical volatility and very poor performance | |
| Net Loss for the year was (10.08 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Artelo Biosciences currently holds about 21.32 M in cash with (8.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.51, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Artelo Biosciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Artelo Biosciences Buy Rating Reaffirmed at HC Wainwright - Defense World |
- Analyzing Artelo Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Artelo Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Artelo Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Artelo Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Artelo Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Artelo Biosciences' stock. These opinions can provide insight into Artelo Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Artelo Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Complementary Tools for Artelo Stock analysis
When running Artelo Biosciences' price analysis, check to measure Artelo Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artelo Biosciences is operating at the current time. Most of Artelo Biosciences' value examination focuses on studying past and present price action to predict the probability of Artelo Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Artelo Biosciences' price. Additionally, you may evaluate how the addition of Artelo Biosciences to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |
Is Artelo Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Artelo Biosciences. If investors know Artelo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Artelo Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.14) | Return On Assets (0.37) | Return On Equity (0.60) |
The market value of Artelo Biosciences is measured differently than its book value, which is the value of Artelo that is recorded on the company's balance sheet. Investors also form their own opinion of Artelo Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Artelo Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Artelo Biosciences' market value can be influenced by many factors that don't directly affect Artelo Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Artelo Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Artelo Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Artelo Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.